ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 738

$986K Total Retail Price of All Prescriptions

Rank: 30 out of 738

768 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 768 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 768 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

5% of this provider’s 1,137 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$121 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ZOLPIDEM TARTRATE 514 49 1 3
TRAZODONE HCL 407 50 2 1
RISPERIDONE 392 59 3 2
SERTRALINE HCL 326 44 4 5
ABILIFY 326 22 4 7
BENZTROPINE MESYLATE 320 11 R 6 6
DIVALPROEX SODIUM 310 28 7 23
FLUOXETINE HCL 241 31 8 8
BUPROPION XL 233 33 9 15
MIRTAZAPINE 232 43 10 10
SEROQUEL XR 224 0 11 13
CYMBALTA 223 33 12 11
LAMOTRIGINE 219 29 13 12
CITALOPRAM HBR 200 35 14 4
SUBOXONE 156 0 15 50
TOPIRAMATE 156 0 15 39
AMPHETAMINE SALT COMBO 155 20 S2 17 37
OLANZAPINE 153 38 18 18
QUETIAPINE FUMARATE 144 12 19 9
PAROXETINE HCL 131 18 20 16
AMITRIPTYLINE HCL 125 29 R 21 47
ALPRAZOLAM 123 35 22 17
ESCITALOPRAM OXALATE 122 13 23 14
HALOPERIDOL 118 0 24 29
VENLAFAXINE HCL ER 112 15 25 19
DIVALPROEX SODIUM ER 109 13 26 24
HYDROXYZINE PAMOATE 92 0 R 27 32
LITHIUM CARBONATE 88 13 28 25
FANAPT 80 0 29 83
LATUDA 80 11 29 64
ZIPRASIDONE HCL 73 0 31 36
BUPROPION HCL SR 70 11 32 22
OXCARBAZEPINE 70 0 32 44
VIIBRYD 67 0 34 71
GABAPENTIN 65 0 35 33
BUSPIRONE HCL 61 15 36 20
TRIHEXYPHENIDYL HCL 60 13 R 37 46
DONEPEZIL HCL 59 26 38 21
INVEGA 58 0 39 61
LORAZEPAM 55 40 40 34
SEROQUEL 54 0 41 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.